UK Pharma Co. Scores Patent For Magic Mushroom Treatment
A U.K.-based mental health care company announced it has been granted a U.S. patent for a formulation that includes an active ingredient in psychedelic mushrooms, which the company is researching as...To view the full article, register now.
Already a subscriber? Click here to view full article